Peer Review

Applications undergo an internal pre-review process to ensure all eligibility requirements are met. Applications considered eligible will then go through a rigorous external peer review process. The American Lung Association's Review Committees are comprised of accomplished and diverse researchers with the necessary expertise to review and assess each proposal for its scientific merits, technical feasibility, innovation and significance in meeting the organization's mission. All applicants  will be provided with written critiques.

Peer review meetings will take place in the spring. Outcome notifications, along with reviewer critiques, are emailed to all applicants in May or June. We cannot respond to telephone or email requests for results during the review period.

Funding Statistics

Proposals are funded based on the results of the peer review process. The American Lung Association only funds those applications deemed of highest quality. There are no requirements in the number of applications that must be funded for each grant mechanism. Therefore, the numbers of grants funded are not an indication of the importance of one grant mechanism over the other and will change on a yearly basis.
 Funding results for a recent review cycle(s) are as follows:

Grant Mechanism

2024 Applications Received

Applications Funded

 Percentile Payline

Lung Cancer Discovery Award

 29

9

26.60%

Emerging Respiratory Pathogen Award 

 30

10

32.20%

Innovation Award

 42

7

32.70%

Hastings Innovation Award for Interstitial Lung Disease

11

4

8.6%

Allergic Respiratory Diseases Research Award  

 3

1

8.80%

Catalyst Award  

 46

16

33.30%

Dalsemer Interstitial Lung Disease Award

8

2

3.40%

Public Policy and Public Health Award  
9229.40%
Total
17851

 

Abstracts of funded research are reported in our annual Research Awards Nationwide.

Page last updated: August 27, 2024

Freedom From Smoking Clinic - Parma, OH
Parma, OH | Aug 20, 2024
Freedom From Smoking Clinic - Cleveland, OH
Cleveland, OH | Sep 25, 2024